Alere Inc (ALR)-Medical Equipment-Deals and Alliances Profile

Alere Inc (ALR)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME361D
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Alere Inc (Alere) is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, women's health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US. Alere offers its products and services to hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers. The company operates through subsidiaries and a network of distributors in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Alere is headquartered in Waltham, Massachusetts, the US.

Alere Inc (ALR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Alere Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Alere Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Alere Inc, Medical Equipment, Deal Details 12

Private Equity 12

Pharos Capital Group Acquires Majority Stake in TechLab 12

Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million 13

Partnerships 13

Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 13

Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 14

Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products 15

VitaPath Genetics Enters Into Licensing Agreement With Alere 16

Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 16

Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 17

Alere Enters Into Co-Development Agreement With AT&T 18

EKF Diagnostics Enters Into Distribution Agreement With Alere 19

Spartan Bioscience Enters Into Distribution Agreement With Alere 20

AdnaGen Extends Licensing Agreement With KellBenx 20

Debt Offering 21

Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023 21

Alere Completes Private Placement Of Notes Due 2020 For US$425 Million 22

Alere Completes Private Placement Of Notes Due 2018 For US$450 Million 23

Asset Transactions 24

QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen 24

Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion 25

Acquisition 26

Alere Acquires US Diagnostics USD60 Million 26

Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 26

Alere Completes Acquisition Of Epocal For Up To US$241 Million 27

Alere Acquires eScreen for USD296 Million 28

Arriva Medical Acquires AmMed Direct For US$23 Million 29

Arriva Medical Acquires Direct Diabetic Source 30

Alere Completes Acquisition Of Medical Automation System 31

Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million 31

Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million 32

Alere Acquires Lab Data Systems 34

Alere Inc-Key Competitors 36

Key Employees 37

Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Recent Developments 45

Financial Announcements 45

Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 45

Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 46

May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 47

Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 48

Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 49

Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 50

Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 51

Legal and Regulatory 53

Mar 09, 2017: Alere Provides Update on Arriva Medical 53

Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 54

Jan 04, 2017: Alere Provides Update on Arriva Medical 55

Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 56

Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 57

Product News 58

Aug 25, 2016: Alere Recalls INRatio and INRatio2 PT/INR Monitoring System Due to Incorrect Test Results 58

Mar 18, 2016: Alere Comments on Alere Anticoagulation Monitoring Technology 60

Other Significant Developments 61

Dec 28, 2016: Alere Provides Update on Arriva Medical 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62

List of Figures

Alere Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Alere Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Alere Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Alere Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Alere Inc, Medical Equipment, Key Facts, 2016 1

Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Alere Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Alere Inc, Deals By Market, 2011 to YTD 2017 9

Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Pharos Capital Group Acquires Majority Stake in TechLab 12

Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million 13

Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 13

Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 14

Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products 15

VitaPath Genetics Enters Into Licensing Agreement With Alere 16

Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 16

Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 17

Alere Enters Into Co-Development Agreement With AT&T 18

EKF Diagnostics Enters Into Distribution Agreement With Alere 19

Spartan Bioscience Enters Into Distribution Agreement With Alere 20

AdnaGen Extends Licensing Agreement With KellBenx 20

Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023 21

Alere Completes Private Placement Of Notes Due 2020 For US$425 Million 22

Alere Completes Private Placement Of Notes Due 2018 For US$450 Million 23

QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen 24

Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion 25

Alere Acquires US Diagnostics USD60 Million 26

Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 26

Alere Completes Acquisition Of Epocal For Up To US$241 Million 27

Alere Acquires eScreen for USD296 Million 28

Arriva Medical Acquires AmMed Direct For US$23 Million 29

Arriva Medical Acquires Direct Diabetic Source 30

Alere Completes Acquisition Of Medical Automation System 31

Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million 31

Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million 32

Alere Acquires Lab Data Systems 34

Alere Inc, Key Competitors 36

Alere Inc, Key Employees 37

Alere Inc, Subsidiaries 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Alere Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16088
Site License
USD 500 INR 32175
Corporate User License
USD 750 INR 48263

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com